IP Group news .

IP Group plc

Ground-breaking data demonstrate tissue repair with portfolio company, Istesso’s novel investigational medicines

IP Group plc

Share buyback programme update

IP Group plc

Portfolio company AccelerComm secures $15m funding to speed adoption of technology for space-based 5G networks

IP Group plc

Hinge Health IPO priced at top end of the range

IP Group plc

Annual results 2024

IP Group plc

Portfolio company Hinge Health files for IPO

IP Group plc

Portfolio company Istesso provides update on Phase 2b study of leramistat in rheumatoid arthritis

IP Group plc

Share buyback programme update

IP Group plc

Two quoted life sciences portfolio companies receive cash offers

IP Group plc

£119m of initial cash proceeds following completion of sale of portfolio company Featurespace to Visa